Articles by Keyword for

Zometa, a bisphosphonate drug used to prevent bone metastases in women with breast cancer, was serendipitously found to reduce metastases and extend life by 37%. This translates to 4-5 out of 100 being alive 7 years later. An IV infusion was given every six months for 3 years. Cost is between $1500 and $2500 per injection. All patients were early-stage and had...

Only about 10% of cancers are caused by genetic factors such as the BRACA gene defect. Factors increasing the risk for breast cancer such as estrogen, environmental factors, unhealthy fats, alcohol, low fiber diet, smoking, birth control pills, and HRT, are reviewed. Methylation and related factors such as B12, folic acid, and B6 influence DNA repair and...

Women with dense breasts from fibrocystic breast disease have up to a six time increased risk for developing breast cancer that is especially aggressive and often involves women under the age of 50. There is no accurate and affordable mainstream test to differentiate fibrocystic disease from breasts cancer. Yet digital mammograms are are relied upon to screen...

  Women with metastatic breast cancer are 40% more likely to survive if they have the primary tumor removed. It appears that the primary tumor feeds the cancer. Thus, it appears that removing the primary cancer in breast cancer is a good idea.        

  When you don't know the outcome of a medical test, the uncertainty of not knowing can be more stressful and anxiety provoking than the worst possible outcome. Our minds tend to worry and we need to learn to "worry well." Chronic stress suppresses immunity and sets the stage for further inflammation and progression of whatever disease...

It looks like there is a trend in breast cancer and now lung cancer of not removing the lymph nodes, so when should lymph nodes be removed, or should they be removed?  What doctors are trying to do a lot of the time with cancer, is make an assessment of how extensive the cancer is, how far it has spread, and then based on that, they try to pick the treatments...

The conclusion of a 25 year prospective study published in the British Medical Journal in February of 2014 was that screening mammograms not only do not save lives but also lead to a 22% over-diagnosis that leads to unnecessary testing and treatment in women between the ages of 50 and 69.  After all these years of policy set by governments, research...